APOA1 anticorps

N° du produit ABIN5596808

Détail du produit anti-APOA1 anticorps

Antigène: APOA1 (Apolipoprotein A-I (APOA1))

Reactivité: Souris

Hôte: Chèvre

Clonalité: Polyclonal

Conjugué: Cet anticorp APOA1 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunoprecipitation (IP)

Réactivité croisée (Details): Typically less than 1% cross-reactivity against other types of apoLipoprotein was detected by ELISA against purified standards. This antibody reacts with mouse apoLipoprotein A-I and has negligible cross-reactivity with Type A-II, B, C-I, C-II, C-III, E and J apoLipoproteins. Specific cross-reaction of anti-apoLipoprotein antibodies with antigens from other species has not been determined. Non-specific cross-reaction of anti-apoLipoprotein antibodies with other mouse serum proteins is negligible.

Purification: This product has been prepared by immunoaffinity chromatography using immobilized antigens followed by extensive cross-adsorption against other apoLipoproteins and human serum proteins to remove any unwanted specificities.

Immunogène:

Immunogen: apoLipoprotein Type A-I was isolated from mouse plasma by density gradient centrifugation followed by HPLC purification.

Immunogen Type: Native Protein

Isotype: IgG

Information d'application

Indications d'application:

Immunohistochemistry Dilution: 1:250 - 1:500

Application Note: Anti-apoLipoprotein antibodies have been used for indirect trapping ELISA for quantitation of antigen in serum using a standard curve, for immunoprecipitation and for western blotting for highly sensitive qualitative analysis.

Western Blot Dilution: 1:500 - 1:1,000

Immunoprecipitation Dilution: 1:100

ELISA Dilution: 1:5,000 - 1:10,000

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1.0 mg/mL

Buffer:

Buffer: 0.125 M Sodium Borate, 0.075 M Sodium Chloride, 0.005 M EDTA, pH 8.0

Stabilizer: None

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store vial at 4° C prior to opening. This product is stable at 4° C as an undiluted liquid. Dilute only prior to immediate use. For extended storage, mix with an equal volume of glycerol, aliquot contents and freeze at -20° C or below. Avoid cycles of freezing and thawing.

Date de péremption: 12 months

Références pour anticorps anti-APOA1 (ABIN5596808)

Han, Tang, Guevara, Wei, Wietecha, Shao, Subramanian, Omer, Wang, OBrien, Marcovina, Wight, Vaisar, de Beer, de Beer, Osborne, Elkon, Chait: "Serum amyloid A impairs the antiinflammatory properties of HDL." dans: The Journal of clinical investigation, Vol. 126, Issue 1, pp. 266-81, (2016) (PubMed).

Tóth, Szegedi, Varga, Juhász, Horváth, Borbély, Csibrány, Alföldi, Lénárt, Penke, Sántha: "Overexpression of Hsp27 ameliorates symptoms of Alzheimer's disease in APP/PS1 mice." dans: Cell stress & chaperones, Vol. 18, Issue 6, pp. 759-71, (2014) (PubMed).

Fitz, Cronican, Saleem, Fauq, Chapman, Lefterov, Koldamova: "Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice." dans: The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 32, Issue 38, pp. 13125-36, (2012) (PubMed).

Tadin-Strapps, Peterson, Cumiskey, Rosa, Mendoza, Castro-Perez, Puig, Zhang, Strapps, Yendluri, Andrews, Pickering, Rice, Luo, Chen, Tep, Ason, Somers, Sachs, Bartz, Tian, Chin, Hubbard, Wong, Mitnaul: "siRNA-induced liver ApoB knockdown lowers serum LDL-cholesterol in a mouse model with human-like serum lipids." dans: Journal of lipid research, Vol. 52, Issue 6, pp. 1084-97, (2011) (PubMed).

Champy, Le Voci, Selloum, Peterson, Cumiskey, Blom: "Reduced body weight in male Tspan8-deficient mice." dans: International journal of obesity (2005), Vol. 35, Issue 4, pp. 605-17, (2011) (PubMed).

Chen, Burton, Song, McNamara, Langella, Cianetti, Chang, Wang: "An apoA-I mimetic peptide increases LCAT activity in mice through increasing HDL concentration." dans: International journal of biological sciences, Vol. 5, Issue 5, pp. 489-99, (2009) (PubMed).

Hu, Abe-Dohmae, Tsujita, Iwamoto, Ogikubo, Otsuka, Kumon, Yokoyama: "Biogenesis of HDL by SAA is dependent on ABCA1 in the liver in vivo." dans: Journal of lipid research, Vol. 49, Issue 2, pp. 386-93, (2008) (PubMed).

van der Hoorn, de Haan, Berbée, Havekes, Jukema, Rensen, Princen: "Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice." dans: Arteriosclerosis, thrombosis, and vascular biology, Vol. 28, Issue 11, pp. 2016-22, (2008) (PubMed).

van der Hoogt, de Haan, Westerterp, Hoekstra, Dallinga-Thie, Romijn, Princen, Jukema, Havekes, Rensen: "Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expression." dans: Journal of lipid research, Vol. 48, Issue 8, pp. 1763-71, (2007) (PubMed).

Allen, Piontek, Garrett-Mayer, Garcia-Gonzalez, Gorelick, Germino: "Loss of polycystin-1 or polycystin-2 results in dysregulated apolipoprotein expression in murine tissues via alterations in nuclear hormone receptors." dans: Human molecular genetics, Vol. 15, Issue 1, pp. 11-21, (2005) (PubMed).

Détails sur APOA1

Antigène: APOA1 (Apolipoprotein A-I (APOA1))

Autre désignation: APOLIPOPROTEIN A-I (APOA1 Produits)

Synonymes: anticorps Alp-1, anticorps Apoa-1, anticorps Brp-14, anticorps Ltw-1, anticorps Lvtw-1, anticorps Sep-1, anticorps Sep-2, anticorps Sep2, anticorps apoA-I, anticorps apoa, anticorps apoa1, anticorps cb49, anticorps wu:fb33f01, anticorps zgc:103718, anticorps MGC64335, anticorps MGC89745, anticorps Apo-AI, anticorps ApoA-I, anticorps APOA1, anticorps LOC100136573, anticorps apoa-i, anticorps ApoAI, anticorps apolipoprotein A1, anticorps apolipoprotein A-I, anticorps apolipoprotein A-Ia, anticorps apolipoprotein A-I S homeolog, anticorps apolipoprotein A4, anticorps APOA1, anticorps Apoa1, anticorps apoa1a, anticorps apoa1.S, anticorps apoa1, anticorps LOC100136573, anticorps apoa-i, anticorps apoa4

Sujet:

Synonyms: APOA1 antibody, APOA1/APOC3 fusion gene antibody, Apolipoprotein A I precursor antibody, Apolipoprotein AI antibody, Apolipoprotein of high density lipoprotein antibody

Background: Anti Apolipoprotein A-I antibody recognizes the gene product of APOA1. Apolipoprotein promotes cholesterol efflux from tissues to the liver for excretion. Apolipoprotein A-I is the major protein component of high density lipoprotein (HDL) in the plasma. Synthesized in the liver and small intestine, it consists of two identical chains of 77 amino acids, an 18-amino acid signal peptide is removed co-translationally and a 6-amino acid propeptide is cleaved post-translationally. Variation in the latter step, in addition to modifications leading to so-called isoforms, is responsible for some of the polymorphism observed. APOA1 is a cofactor for lecithin cholesterolacyltransferase (LCAT) which is responsible for the formation of most plasma cholesteryl esters. The APOA1, APOC3 and APOA4 genes are closely linked in both rat and human genomes. The A-I and A-IV genes are transcribed from the same strand, while the C-III gene is transcribed convergently in relation to A-I. Defects in the apolipoprotein A-1 gene are associated with HDL deficiency and Tangier disease. This antibody is suitable for cardiovascular research.

Gene Name: APOA1

ID gène: 11806

UniProt: Q00623

Pathways: Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Lipid Metabolism